O.M.Folomeeva
https://doi.org/10.14412/1995-4484-2008-423
For citations:
- -. O.M.Folomeeva. Rheumatology Science and Practice. 2008;46(5):92-93. (In Russ.) https://doi.org/10.14412/1995-4484-2008-423
Views:
493
Popular articles
Vol 58, No 2 (2020)
Vol 58, No 5 (2020)
Vol 59, No 2 (2021)
Vol 59, No 3 (2021)
Vol 59, No 3 (2021)
Vol 59, No 4 (2021)
Vol 59, No 5 (2021)
Vol 59, No 6 (2021)
Article Tools
Email this article (Login required)
Email the author (Login required)
Email this article (Login required)
Email the author (Login required)
About the Author
Keywords
COVID-19
ankylosing spondylitis
axial spondyloarthritis
biological agents
bone mineral density
cytokines
glucocorticoids
gout
inflammation
methotrexate
osteoarthritis
osteoporosis
psoriatic arthritis
quality of life
rheumatic diseases
rheumatoid arthritis
rituximab
systemic lupus erythematosus
systemic sclerosis
tocilizumab
treatment
